<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04976842</url>
  </required_header>
  <id_info>
    <org_study_id>OFA 1</org_study_id>
    <nct_id>NCT04976842</nct_id>
  </id_info>
  <brief_title>Opioid-free Anesthesia and Acute Postoperative Pain</brief_title>
  <official_title>Acute Postoperative Pain in Opioid-free Anesthesia After Urological Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Attikon Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Attikon Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Control of intraoperative and postoperative pain with the use of opioids constitutes normal&#xD;
      practice. Opioid free anesthesia (OFA) is a relatively recent anesthesiology practice&#xD;
      according to which opioids are not administered during surgery and are avoided&#xD;
      postoperatively. Opioid free anesthesia seems to provide better quality of postoperative&#xD;
      analgesia while protecting the patient from the side effects of opioids such as respiratory&#xD;
      depression, postoperative nausea and vomiting (PONV), opioid induced hyperalgesia and&#xD;
      postoperative cognitive dysfunction. The aim of this study is to investigate the possible&#xD;
      difference in the intensity of postoperative pain (based on the numeric rating scale 0-10)&#xD;
      and the presence of PONV in patients undergoing transurethral urologic surgery under general&#xD;
      anesthesia, when patients receive randomly either opioid free anesthesia (OFA) or opioid&#xD;
      based anesthesia (OBA).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aimed to study postoperative pain after opioid free anesthesia or opioid based&#xD;
      anesthesia after urologica; procedures. The two study groups opioid free (OFA) and opioid&#xD;
      based (OBA) were as follows:&#xD;
&#xD;
      OFA: Anesthesiology technique based on Mulier protocol. Before induction, loading dose of&#xD;
      dexmedetomidine 0,25mcg/kg (max 20mcg). Induction with dexmedetomidine 0,1mcg/kg, lidocaine&#xD;
      1mg/kg, ketamine 0,1mg/kg plus propofol 2mg/kg plus rocuronium1mg/kg IBW (if required).&#xD;
      Maintenance with dexmedetomidine 0,1mcg/kg/h, lidocaine 1mg/kg/h, ketamine 0,1mg/kg/h and&#xD;
      propofol infusion adjusted according to bispectral index indication ( BIS maintained 40-60).&#xD;
      15 minutes prior to end of surgery, the dose of drugs is reduced to dexmedetomidine&#xD;
      0,05mcg/kg/h, lidocaine 0,5mg/kg/h, ketamine 0,05mg/kg/h.&#xD;
&#xD;
      OBA: Total intravenous anesthesia with propofol for maintenance of anesthesia. Fentanyl&#xD;
      2mcg/kg only at induction and infusion of propofol and remifentanil for maintenance, with&#xD;
      doses adjusted according to bispectral index indication ( BIS maintained 40-60).&#xD;
&#xD;
      Both groups receive ranitidine 50mg, dexamethasone 4 mg and paracetamol 1g iv 15 min before&#xD;
      the end of surgery. Postoperative analgesia for both groups consists of paracetamol 3g/24h&#xD;
      iv, rescue analgesia with tramadol 1mg/kg iv max x3, rescue for PONV ondacetron 4 mg iv.&#xD;
&#xD;
      The outcomes assessed were:&#xD;
&#xD;
      Primary outcome:&#xD;
&#xD;
        1. Intensity of acute postoperative pain (NRS 0-10), time frame up to 24h postoperatively&#xD;
&#xD;
        2. Nausea and vomiting&#xD;
&#xD;
      Secondary outcome:&#xD;
&#xD;
        1. Change in minimental state evaluation test, time frame pre-op, 1h post-op, at discharge&#xD;
&#xD;
        2. Severe postoperative adverse effect related to anesthesia (postoperative hypoxemia,&#xD;
           ileus, postoperative cognitive dysfunction)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">August 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>2 groups of patients assigned to either opioid-free anesthesia or opioid-based anesthesia were studied in a randomized manner as for postoperative pain and cognitive dysfunction</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>the investigator assessing outcome did not know the kind of anesthesia the patient received</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>baseline and 24 hours</time_frame>
    <description>Intensity of acute postoperative pain (measured by numeric rating scale NRS 0-10), time frame up to 24h postoperatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative cognitive dysfunction</measure>
    <time_frame>baseline and 24 hours</time_frame>
    <description>Change in minimental state evaluation test up to 24 hours postoperatively</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Anesthesia</condition>
  <condition>Postoperative Pain</condition>
  <condition>Cognitive Impairment, Variable</condition>
  <arm_group>
    <arm_group_label>Opioid-free anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Opioid free anesthesia protocol for urological procedurs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Opioid-based anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Opioid based anesthesia protocol for urological procedures</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OFA</intervention_name>
    <description>Anesthesiology technique based on Mulier protocol. Before induction, loading dose of dexmedetomidine 0,25mcg/kg (max 20mcg). Induction with dexmedetomidine 0,1mcg/kg, lidocaine 1mg/kg, ketamine 0,1mg/kg plus propofol 2mg/kg plus rocuronium1mg/kg IBW (if required). Maintenance with dexmedetomidine 0,1mcg/kg/h, lidocaine 1mg/kg/h, ketamine 0,1mg/kg/h and propofol infusion adjusted according to bispectral index indication ( BIS maintained 40-60). 15 minutes prior to end of surgery, the dose of drugs is reduced to dexmedetomidine 0,05mcg/kg/h, lidocaine 0,5mg/kg/h, ketamine 0,05mg/kg/h.</description>
    <arm_group_label>Opioid-free anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>OBA</intervention_name>
    <description>Total intravenous anesthesia with propofol for maintenance of anesthesia. Fentanyl 2mcg/kg only at induction and infusion of propofol and remifentanil for maintenance, with doses adjusted according to bispectral index indication ( BIS maintained 40-60).</description>
    <arm_group_label>Opioid-based anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged&gt;18 years old&#xD;
&#xD;
          -  ASA I-III&#xD;
&#xD;
          -  Patients scheduled for elective transurethral urologic surgery with general anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • Patient refusal&#xD;
&#xD;
               -  Use of opioids pre-op&#xD;
&#xD;
               -  Inability to read or write&#xD;
&#xD;
               -  Known psychiatric disease under medication&#xD;
&#xD;
               -  Dementia&#xD;
&#xD;
               -  Severe liver and renal disease&#xD;
&#xD;
               -  Known allergy to drugs used&#xD;
&#xD;
               -  Known arrhythmia (2nd-3rd AV block, acute unstable angina, acute myocardial&#xD;
                  infarction in the past 6 weeks or severe cardiac problem-condition)&#xD;
&#xD;
               -  Heart rate&lt;45 bpm&#xD;
&#xD;
               -  Pre-op minimental test&lt;23&#xD;
&#xD;
               -  Major surgery complications (hemorrhage with need for transfusion)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>CHRΥSANTHI BATISTAKI, MD, PHD</last_name>
    <phone>00302105832371</phone>
    <email>chrysabatistaki@yahoo.gr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paraskevi Matsota, MD, PHD</last_name>
    <phone>00302105832371</phone>
    <email>matsota@yahoo.gr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>2nd Department of Anesthesiology, Attikon Hospital, 1 Rimini str.</name>
      <address>
        <city>Athens</city>
        <zip>12462</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chrysanthi Batistaki, MD, PhD</last_name>
      <phone>0030 210 5832371</phone>
      <email>chrysabatistaki@yahoo.gr</email>
    </contact>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 10, 2021</study_first_submitted>
  <study_first_submitted_qc>July 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2021</study_first_posted>
  <last_update_submitted>August 7, 2021</last_update_submitted>
  <last_update_submitted_qc>August 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Attikon Hospital</investigator_affiliation>
    <investigator_full_name>Chrysanthi Batistaki</investigator_full_name>
    <investigator_title>Associate Professor of Anaesthesiology</investigator_title>
  </responsible_party>
  <keyword>ANESTHESIA</keyword>
  <keyword>OPIOIDS</keyword>
  <keyword>PAIN</keyword>
  <keyword>COGNITIVE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

